Product image of Levosimendan Kalceks (Levosimendan) supplied by GNH India

Levosimendan Kalceks

Active Ingredient:
Levosimendan
Origin:
EU

Levosimendan Kalceks (Levosimendan)

Levosimendan, the active ingredient in Levosimendan Kalceks, is a calcium sensitizer / inodilator presented as a solution for injection for intravenous use. It treats acute decompensated heart failure in adult patients with the aim of improving cardiac output and relieving symptoms of congestion.

GNH India supplies Levosimendan Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide, with established quality‑assurance processes and regulatory approvals across EU markets, and reliable cold‑chain logistics for injectable products.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Levosimendan is used in the management of acute decompensated heart failure, a condition characterized by sudden worsening of cardiac function.
  • Acute decompensated heart failure: improves cardiac output and reduces pulmonary congestion.
  • Cardiogenic shock: provides inotropic support while reducing afterload.
  • Low cardiac output syndrome after cardiac surgery: helps maintain hemodynamic stability.

How It Works

  • Levosimendan increases myocardial contractility by binding to troponin C and enhancing its sensitivity to calcium, without raising intracellular calcium levels. Simultaneously, it opens ATP‑sensitive potassium channels in vascular smooth muscle, causing vasodilation and reduced afterload, which together improve cardiac output in heart‑failure patients.

Side Effects

Levosimendan may be associated with a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Nausea: occasional gastrointestinal upset.
  • Hypotension: transient drop in blood pressure.
  • Tachycardia: increased heart rate.
  • Arrhythmia: occasional ectopic beats.
  • Flushing: warm sensation and reddening of skin.

Serious or Rare Side Effects

  • Severe hypotension: may require intervention.
  • Ventricular arrhythmias: potentially life‑threatening.
  • Myocardial ischemia: chest pain or ECG changes.
  • Allergic reactions: rash, pruritus, or anaphylaxis.
  • Liver enzyme elevation: abnormal hepatic function tests.
  • Thrombocytopenia: reduced platelet count.

Precautions & Warnings

  • When using Levosimendan, clinicians should consider several safety aspects.
  • Renal impairment: monitor renal function and adjust infusion if needed.
  • Hepatic impairment: use with caution in severe liver disease.
  • Hypotension: avoid rapid infusion in patients with low blood pressure.
  • Concurrent vasodilators: increase risk of hypotension.
  • Electrolyte disturbances: correct before administration.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Levosimendan can interact with other cardiovascular agents, requiring careful management.

Major Interactions (Avoid)

  • Sodium nitroprusside: additive vasodilation leading to severe hypotension.
  • Phosphodiesterase inhibitors (e.g., milrinone): risk of excessive inotropy and arrhythmia.
  • Beta‑blockers: may blunt desired inotropic effect.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors: monitor blood pressure for additive hypotensive effect.
  • Diuretics: watch for electrolyte shifts and volume depletion.
  • Anticoagulants: monitor for bleeding if hypotension occurs.

Frequently Asked Questions

Levosimendan Kalceks is an injectable formulation of levosimendan indicated for the treatment of acute decompensated heart failure, where rapid improvement of cardiac output and reduction of congestion are required.

Levosimendan works by sensitizing cardiac troponin C to calcium, which enhances contractility without increasing intracellular calcium, and by opening ATP‑sensitive potassium channels in vascular smooth muscle, producing vasodilation and lowering afterload.

The dosing regimen for Levosimendan Kalceks is determined by the prescribing clinician based on the patient’s clinical status, weight, and response; it is administered intravenously under medical supervision.

Safety data for levosimendan in pregnancy and lactation are limited; it should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision rests with the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required) and import documentation.

Unlike traditional catecholamine inotropes, levosimendan increases contractility without raising intracellular calcium, which may reduce the risk of arrhythmias. It also provides vasodilatory effects, offering a combined inotropic and afterload‑reducing profile that can be advantageous in certain heart‑failure scenarios.

Levosimendan Kalceks should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability.

The medication is supplied as a sterile solution for injection and is administered intravenously, typically as a loading dose followed by a continuous infusion, under continuous hemodynamic monitoring in a hospital setting.

Serious risks include severe hypotension, ventricular arrhythmias, myocardial ischemia, and rare allergic reactions. Patients should be closely monitored for blood pressure, heart rhythm, and signs of ischemia throughout the infusion.

Levosimendan is contraindicated in patients with known hypersensitivity to the drug, uncontrolled severe hypotension, or those receiving certain vasodilators that could precipitate dangerous blood‑pressure drops. Clinical judgment is required for patients with severe hepatic impairment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levosimendan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT